Home
ANAB
ANAB News

Latest AnaptysBio Inc. (ANAB) News on November 25, 2024

Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher

Simply Wall St.

9 days ago

Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher

AnaptysBio (ANAB) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

16 days ago

AnaptysBio (ANAB) Upgraded to Buy: What Does It Mean for the Stock?

Down -32.84% in 4 Weeks, Here's Why You Should You Buy the Dip in AnaptysBio (ANAB)

Zacks

17 days ago

Down -32.84% in 4 Weeks, Here's Why You Should You Buy the Dip in AnaptysBio (ANAB)

AnaptysBio Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

18 days ago

AnaptysBio Third Quarter 2024 Earnings: Beats Expectations

AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates

Zacks

19 days ago

AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates

Anaptys Announces Participation in November and December Investor Conferences

GlobeNewswire

19 days ago

Anaptys Announces Participation in November and December Investor Conferences

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

19 days ago

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

MT Newswires

a month ago

AnaptysBio Shares Fall After Eli Lilly Removes Arthritis Drug Peresolimab From Pipeline

Anaptys Announces Participation in September Investor Conferences

GlobeNewswire

3 months ago

Anaptys Announces Participation in September Investor Conferences

Why AnaptysBio Was Such a Healthy Stock This Week

Motley Fool

3 months ago

Why AnaptysBio Was Such a Healthy Stock This Week

MT Newswires

3 months ago

Truist Adjusts Price Target on AnaptysBio to $30 From $20, Maintains Hold Rating

AnaptysBio Surges After Sanofi Takes A Stake In $100 Million Offering

Investor's Business Daily

3 months ago

AnaptysBio Surges After Sanofi Takes A Stake In $100 Million Offering

MT Newswires

3 months ago

AnaptysBio Prices $100 Million Common Stock Offering

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

GlobeNewswire

3 months ago

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

Investors in AnaptysBio (NASDAQ:ANAB) have seen respectable returns of 74% over the past year

Simply Wall St.

3 months ago

Investors in AnaptysBio (NASDAQ:ANAB) have seen respectable returns of 74% over the past year

MT Newswires

4 months ago

Wedbush Adjusts Price Target on AnaptysBio to $42 From $34, Maintains Outperform Rating

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Misses Revenue Estimates

Zacks

4 months ago

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Misses Revenue Estimates

Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

4 months ago

Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Zacks

4 months ago

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Benzinga

4 months ago

AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

Zacks

4 months ago

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

MT Newswires

4 months ago

JPMorgan Upgrades AnaptysBio to Overweight From Neutral, Adjusts Price Target to $69 From $29

Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?

Zacks

5 months ago

Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?

Industry Analysts Just Upgraded Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts By 16%

Simply Wall St.

6 months ago

Industry Analysts Just Upgraded Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts By 16%

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

Zacks

7 months ago

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update

Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)

GlobeNewswire

7 months ago

Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)

Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties

GlobeNewswire

7 months ago

Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

7 months ago

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

Zacks

7 months ago

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

Actym Therapeutics Appoints Thomas Smart as CEO

PR Newswire

7 months ago

Actym Therapeutics Appoints Thomas Smart as CEO

Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week

Motley Fool

7 months ago

Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week

Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.

Zacks

7 months ago

Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.

Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts

Simply Wall St.

8 months ago

Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts

What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock

Zacks

8 months ago

What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock

Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade

Zacks

8 months ago

Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Zacks

8 months ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates

Zacks

8 months ago

AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates

Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for

Zacks

9 months ago

Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for

Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting

GlobeNewswire

9 months ago

Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

9 months ago

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?

13 Best Short Squeeze Stocks To Buy Now

Insider Monkey

9 months ago

13 Best Short Squeeze Stocks To Buy Now

Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?

Heartland Express (HTLD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

10 months ago

Heartland Express (HTLD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference

GlobeNewswire

10 months ago

Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference

Associated Press Finance

10 months ago

Hope Bancorp: Q4 Earnings Snapshot

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

Spirit Airlines Stock Tumbles as JetBlue Warns It Could Walk Away From Merger

Barrons.com

10 months ago

Spirit Airlines Stock Tumbles as JetBlue Warns It Could Walk Away From Merger

Glass Lewis Tells Hollysys Shareholders to Reject $1.7 Billion Offer

Bloomberg

10 months ago

Glass Lewis Tells Hollysys Shareholders to Reject $1.7 Billion Offer

John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal Year 2024 Operating Results Conference Call

GlobeNewswire

10 months ago

John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal Year 2024 Operating Results Conference Call

Newsfile

10 months ago

IAMGOLD Announces Regulatory Approval in France of Buy-Out Offer for Euro Ressources

Reuters

10 months ago

CANADA STOCKS-China hopes help lift Toronto market for fourth day

Reuters

10 months ago

CANADA STOCKS-TSX hits one-week high on materials boost; BoC rate decision in focus

Greenbrier Companies (GBX) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

10 months ago

Greenbrier Companies (GBX) Just Flashed Golden Cross Signal: Do You Buy?

CrossFirst Bankshares (CFB) Q4 Earnings Surpass Estimates

Zacks

10 months ago

CrossFirst Bankshares (CFB) Q4 Earnings Surpass Estimates

GuruFocus.com

10 months ago

CrossFirst Bankshares Inc Reports Record Full Year Earnings for 2023

Associated Press Finance

10 months ago

CrossFirst: Q4 Earnings Snapshot

Why Is BlackBerry (BB) Down 5.3% Since Last Earnings Report?

Zacks

10 months ago

Why Is BlackBerry (BB) Down 5.3% Since Last Earnings Report?

Immatics Announces Proposed Public Offering

GlobeNewswire

10 months ago

Immatics Announces Proposed Public Offering

enCore Energy Provides Update on South Texas Uranium Operations

PR Newswire

10 months ago

enCore Energy Provides Update on South Texas Uranium Operations

Energy And Oil Stocks Scan: Shell Suspends Red Sea Shipments, Dorian LPG Attempts Rebound

Investor's Business Daily

10 months ago

Energy And Oil Stocks Scan: Shell Suspends Red Sea Shipments, Dorian LPG Attempts Rebound

TDCX Inc. Special Committee Engages Financial Advisor and Legal Counsels

Business Wire

10 months ago

TDCX Inc. Special Committee Engages Financial Advisor and Legal Counsels

Diebold Nixdorf Names Frank Baur as Executive Vice President, Operational Excellence

PR Newswire

10 months ago

Diebold Nixdorf Names Frank Baur as Executive Vice President, Operational Excellence

Newmark Completes Offering Of $600 Million Of 7.500% Senior Notes

PR Newswire

10 months ago

Newmark Completes Offering Of $600 Million Of 7.500% Senior Notes

AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares

GuruFocus.com

10 months ago

AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares

Herbalife Wins Two Gold Excellence Awards for Providing Best-In-Class Education and Tools to Help Its Independent Distributors Grow Their Businesses

Business Wire

10 months ago

Herbalife Wins Two Gold Excellence Awards for Providing Best-In-Class Education and Tools to Help Its Independent Distributors Grow Their Businesses

PAR Technology Revolutionizes Hospitality Hardware with the Launch of PAR Wave POS Terminal

Business Wire

10 months ago

PAR Technology Revolutionizes Hospitality Hardware with the Launch of PAR Wave POS Terminal

China’s Export Controls Might Trigger a U.S. Graphite Boom

Oilprice.com

10 months ago

China’s Export Controls Might Trigger a U.S. Graphite Boom

Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade

Zacks

10 months ago

Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade

Tiny Tickers, Tons of Potential: 3 Penny Stocks Set to Soar

InvestorPlace

10 months ago

Tiny Tickers, Tons of Potential: 3 Penny Stocks Set to Soar

Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results

Zacks

10 months ago

Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results

Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024

Zacks

10 months ago

Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024

Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?

Energy Recovery Inc CFO Joshua Ballard Sells 12,500 Shares

GuruFocus.com

a year ago

Energy Recovery Inc CFO Joshua Ballard Sells 12,500 Shares

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Zacks

a year ago

Collegium (COLL) Shares Rise on Financial Outlook for 2024

QFIN vs. RKT: Which Stock Is the Better Value Option?

Zacks

a year ago

QFIN vs. RKT: Which Stock Is the Better Value Option?

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

InvestorPlace

a year ago

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

At US$35.25, Is It Time To Put Napco Security Technologies, Inc. (NASDAQ:NSSC) On Your Watch List?

Simply Wall St.

a year ago

At US$35.25, Is It Time To Put Napco Security Technologies, Inc. (NASDAQ:NSSC) On Your Watch List?

AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago

Simply Wall St.

a year ago

AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago

Getty Realty Corp. Announces 2023 Getty Gives Activity

Business Wire

a year ago

Getty Realty Corp. Announces 2023 Getty Gives Activity

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession

GlobeNewswire

a year ago

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession

Here’s Why Vista Outdoor (VSTO) Rose in Q3

Insider Monkey

a year ago

Here’s Why Vista Outdoor (VSTO) Rose in Q3

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking

Simply Wall St.

a year ago

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking

15 Quality Undervalued Non-Cyclical Stocks to Buy Now

Insider Monkey

a year ago

15 Quality Undervalued Non-Cyclical Stocks to Buy Now

Has Arvinas (ARVN) Outpaced Other Medical Stocks This Year?

Zacks

a year ago

Has Arvinas (ARVN) Outpaced Other Medical Stocks This Year?

Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend

GlobeNewswire

a year ago

Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend

We're Not Very Worried About Digimarc's (NASDAQ:DMRC) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Digimarc's (NASDAQ:DMRC) Cash Burn Rate

Orion S.A. Leads Industry with Four Carbon Black Plants Awarded ISCC PLUS

Business Wire

a year ago

Orion S.A. Leads Industry with Four Carbon Black Plants Awarded ISCC PLUS

Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?

Zacks

a year ago

Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience

PR Newswire

a year ago

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience

Gentherm Announces Laura Kowalchik as New Independent Director

GlobeNewswire

a year ago

Gentherm Announces Laura Kowalchik as New Independent Director

STEWART INFORMATION SERVICES CORPORATION ANNOUNCES CASH DIVIDEND

PR Newswire

a year ago

STEWART INFORMATION SERVICES CORPORATION ANNOUNCES CASH DIVIDEND

How Much Upside is Left in Arlo Technologies (ARLO)? Wall Street Analysts Think 56.35%

Zacks

a year ago

How Much Upside is Left in Arlo Technologies (ARLO)? Wall Street Analysts Think 56.35%

Digimarc Launches Industry-First C2PA Content Credentials Browser Extension

Business Wire

a year ago

Digimarc Launches Industry-First C2PA Content Credentials Browser Extension

Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals

GlobeNewswire

a year ago

Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals

1 Semiconductor Stock Down 30% That It's Time to Buy on the Dip

Motley Fool

a year ago

1 Semiconductor Stock Down 30% That It's Time to Buy on the Dip

Connection Announces Winners of 2023 IT Superhero Awards

Business Wire

a year ago

Connection Announces Winners of 2023 IT Superhero Awards

Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet

Share on Social Networks: